Baxter International

BAXTER 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX

Retrieved on: 
Saturday, September 9, 2023
Class Action Lawsuit, Professional Services, Legal, E pluribus unum, Baxter, David Gal, Baxter International, District court, KSF, Special warfare combatant-craft crewmen, Court, News, NYSE

This action is pending in the United States District Court for the Northern District of Illinois.

Key Points: 
  • This action is pending in the United States District Court for the Northern District of Illinois.
  • Baxter and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • On this news, shares of Baxter fell from $45.68 per share to $41.01 per share, on unusually heavy trading volume.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms.

Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests

Retrieved on: 
Thursday, September 7, 2023
Oncology, Medical Supplies, Health, Hospitals, Genetics, Biotechnology, Baxter, 2005 in television, MBA, Multimedia, École centrale de Lyon, Baxter International, Guerbet, Hospital, Patient, Physician, Laboratory, Engineering, Siemens Healthineers, IVD, Small Business Saturday, Covidien, Pharmaceutical industry, Medical device

Veracyte, Inc. (Nasdaq: VCYT) announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France.

Key Points: 
  • Veracyte, Inc. (Nasdaq: VCYT) announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France.
  • She will lead the global expansion of Veracyte’s tests and will also serve as site lead for the company’s Marseille operations.
  • View the full release here: https://www.businesswire.com/news/home/20230907364591/en/
    Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit.
  • Taine’s extensive international management experience and commercial leadership make her the ideal person to lead the global expansion of Veracyte’s IVD test menu.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 7, 2023
Vaccine, P.C, Biotechnology, Shareholder, Face, Baxter International, RAIN, Baxter, COVID-19, Survival, MANTRA, DHR, Research, Danaher Corporation, Projection, Biophysical environment, Growth, FDA, News, NYSE, Audit, Cryptocurrency, Pharmaceutical industry, Diagnosis

Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.

Key Points: 
  • Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • For more information on the Rain class action go to: https://bespc.com/cases/RAIN
    Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International Inc. (BAX)

Retrieved on: 
Wednesday, September 6, 2023
Face, Baxter, Baxter International, Suite, Court, Defendant, GPM, NYSE, News

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Baxter securities during the Class Period, you may move the Court no later than September 11, 2023 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc. (BAX) Shareholders

Retrieved on: 
Wednesday, September 6, 2023
Telephone, COST, Baxter, CLASS, Baxter International, HOW, NYSE, Face, BAX

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Baxter International Inc. (NYSE: BAX) alleging that the Company violated federal securities laws.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Baxter you have until September 11, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

BAXTER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX

Retrieved on: 
Wednesday, September 6, 2023
Baxter, Baxter International, Court, David Gal, District court, KSF, NYSE, Tourism

NEW ORLEANS, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 11, 2023 to file lead plaintiff applications in a securities class action lawsuit against Baxter International Inc. (NYSE: BAX), if they purchased the Company’s securities between May 12, 2022 and February 8, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 11, 2023 to file lead plaintiff applications in a securities class action lawsuit against Baxter International Inc. (NYSE: BAX), if they purchased the Company’s securities between May 12, 2022 and February 8, 2023, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Northern District of Illinois.
  • If you purchased securities of Baxter and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-bax/ to learn more.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by September 11, 2023.

BAXTER INTERNATIONAL, INC. (NYSE: BAX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Baxter International, Inc.

Retrieved on: 
Tuesday, September 5, 2023
Baxter International, Baxter, District court, Advertising, Complaint, Court, Action Replay, News, NYSE, Kidney disease, Cryptocurrency, Security (finance), Tobacco

If you purchased or acquired Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter International, Inc.

Key Points: 
  • If you purchased or acquired Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter International, Inc.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you purchased or acquired Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter International, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Baxter International Inc.(BAX) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Tuesday, September 5, 2023
CASE, LLP, Face, Telephone, COST, Baxter International, Levi, CLASS, NEXT, Court, NYSE, Cryptocurrency, Baxter

NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter investors who were adversely affected by alleged securities fraud between May 25, 2022 and February 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BAX investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Global Oral Clinical Nutrition Market Predicted to Expand Significantly by 2028, Driven by Rising Chronic Diseases - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 5, 2023
Health, Other Health, GSK plc, Prevalence, Diabetes, Alzheimer's disease, Bayer, Malnutrition, Health care, Abbott Laboratories, Cardiovascular disease, Cancer, Ageing, Nutrient, Sarcopenia, Competition, Baxter International, Market, Incidence, Danone, Cachexia, Patient, Lijun International Pharmaceutical (Holding) Co. Ltd., Risk, Whey, Conditional sentence, Nutricia, Chronic kidney disease, Intake, Chronic, Nestlé, Wound healing, Dietary supplement, Pharmaceutical industry, Dysphagia, Pfizer

The global oral clinical nutrition market is poised for substantial growth during the forecast period due to the increasing prevalence of chronic diseases and a growing emphasis on patient-centric care.

Key Points: 
  • The global oral clinical nutrition market is poised for substantial growth during the forecast period due to the increasing prevalence of chronic diseases and a growing emphasis on patient-centric care.
  • Additionally, the rise in malnutrition and related conditions like sarcopenia and cachexia is boosting the demand for oral clinical nutrition products.
  • Rising Chronic Diseases: The escalating incidence of chronic conditions such as diabetes, cardiovascular disease, and cancer is a significant driver of the global oral clinical nutrition market.
  • The comprehensive Global Oral Clinical Nutrition Market report covers market segmentation by indication, distribution channel, and region, highlighting industry trends and growth drivers.

ROSEN, A LEADING LAW FIRM, Encourages Baxter International Inc. Investors With Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX

Retrieved on: 
Sunday, September 3, 2023
Titan, Face, Class, Baxter, Baxter International, Advertising, Court, NYSE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.